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In many parts of the World, medical male circumcision (MMC) is used as standard 
prevention of care against HIV infection. This is based on seminal reports made over 
10 years ago that removal of the foreskin provides up to 60% protection against HIV 
infection in males and seems currently the best antiretroviral-free prevention strategy 
yet against the global epidemic. We explore the potential mechanisms by which MMC 
protects against HIV-1 acquisition and that one of the oldest, albeit re-invented, rituals 
of removing a foreskin underscores the exploitative nature of HIV on the anatomy and 
tissue of the uncircumcised penis. Furthermore, foreskin removal also reveals how males 
acquire HIV, and in reality, the underlying mechanisms of MMC are not known. We argue 
that the normal sequelae of inflammation in the male genital tract (MGT) for protec-
tion from sexually transmitted infections (STI)-induced pathology represents a perfect 
immune and microbial ecosystem for HIV acquisition. The accumulation of HIV-1 target 
cells in foreskin tissue and within the urethra in response to STIs, both during and after 
resolution of infection, suggests that acquisition of HIV-1, through sexual contact, makes 
use of the natural immune milieu of the MGT. Understanding immunity in the MGT, the 
movement of HIV-1 target cells to the urethra and foreskin tissue upon encounter with 
microbial signals would provide more insight into viral acquisition and lay the foundation 
for further prevention strategies in males that would be critical to curb the epidemic in all 
sexual partners at risk of infection. The global female-centric focus of HIV-1 transmission 
and acquisition research has tended to leave gaps in our knowledge of what determines 
HIV-1 acquisition in men and such understanding would provide a more balanced and 
complete view of viral acquisition.
Keywords: Hiv-1, medical male circumcision, sexually transmitted infections, inflammation, risk factors, 
acquisition, exploitation
iNTRODUCTiON
There are approximately 35 million people living with HIV globally with Sub-Saharan Africa (SSA) 
accounting for more than two-thirds of global HIV/AIDS infections (1). Adolescent girls and 
young women are disproportionately affected by HIV in SSA, and 58% of the population living 
with HIV are estimated to be women (1). The high prevalence of HIV acquisition in females is 
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most likely to be multifactorial, associated with the presence of 
STIs, genital inflammation, and exogenous hormone contracep-
tive use (2, 3). There are also sociodemographic factors that may 
underlie higher prevalence in women, such as age discrepancies 
in relationships, gender-power imbalances, and gender-based 
violence that contribute the higher rates of infection in young 
women (2, 3). What is perhaps missing in these equations is how 
males acquire HIV, as male-to-female transmission is likely the 
source of transmission and a driver behind the high rates of infec-
tion measured in women. Men who have sex with men (MSM) 
are 19 times more likely to be living with HIV than the general 
population (4) and the prevalence of HIV in MSM is rising in 
several parts of the world (5). Little is known about the biological 
determinants of HIV transmission in male-to-male, male-to-
female, or female-to-male sexual networks underlying the high 
prevalence of HIV in high-risk groups such as adolescents in SSA 
and MSM. One other possible determinant, perhaps overlooked, 
is that a high proportion MSM in Africa also report recent female 
sexual partners (6). HIV genotype studies at the early stages of 
the epidemic in South Africa showed that subtype B HIV-1 
was confined mostly to the MSM community while subtype C 
circulated mostly in the heterosexual population, suggesting two 
separate HIV-1 introductions into this region (7). More recent 
studies in South Africa, Kenya and Senegal show that this has 
changed with MSM predominately being infected with the same 
variants as the heterosexual population (8–10). Conceivably, this 
might suggest a homogenization of epidemics between hetero-
sexual and MSM sexual networks in the regions with the highest 
global prevalence of HIV (8, 10). Although other reviews focus 
on factors that influence female risks of HIV acquisition, few have 
focused on possible determinants of risk factors in males, which 
likely provides a niche in the male genital tract (MGT) conducive 
for HIV acquisition.
The low estimates of HIV transmission risk per sex act between 
males and females do little to explain the magnitude of the HIV 
epidemic, both globally and in SSA. Recent meta-analyses have 
reported the risk of heterosexual HIV acquisition in developed 
countries (expressed per 10,000 sexual exposures) to be four for 
insertive and eight for receptive penile–vaginal intercourse (11). 
The same analysis reports a significantly higher risk estimate for 
the MSM population with the risk of HIV acquisition to be 138 
for receptive and 11 for insertive anal intercourse per 10,000 
exposures (11). Estimates of the risk of HIV acquisition in SSA 
are difficult to accurately determine due to substantial heteroge-
neity in published data. Meta analyses from 14 sites in eastern and 
southern Africa have estimated that both men and women are at 
a higher risk of HIV acquisition through heterosexual contact 
when compared to data in developed countries: 10 and 9 per 
10,000 exposures, respectively (12). These estimates raise relevant 
and important questions. Why is the magnitude of the HIV epi-
demic so high in SSA? Are there cofactors, both biological and/
or social, that might explain the high rates of global heterosexual 
acquisition of HIV? HIV acquisition risk is unlikely to be defined 
by a “one size fits all” transmission probability; where age, other 
sexually transmitted infections (STIs), circumcision status, dis-
ease stage, antiretroviral (ARV) use, viral load, and viral subtype, 
all contribute to the efficiency of viral transmission (13).
There is no doubt that current research on HIV acquisition 
and prevention in females is of utmost importance, but this focus 
leaves large gaps of knowledge in the determinants of HIV acqui-
sition, and hence transmission, in males. We know that medical 
male circumcision (MMC) is 56–61% effective at preventing HIV 
acquisition in men (13–15), but we do not fully understand how 
circumcision protects against HIV and other STIs at a structural, 
cellular, and molecular level. That such an ancient ritual of cir-
cumcision, albeit modernized, can have such a profound effect on 
preventing viral acquisition in males underscores the exploitative 
nature of HIV on the anatomy and tissue of the uncircumcised 
penis. How does HIV use the MGT environment and anatomical 
structures to promote its acquisition in men?
FOReSKiN BARRieR iNTeGRiTY  
AND iMMUNiTY
The protective effect of circumcision against HIV infection indi-
cates that the foreskin is an important entry point of HIV in the 
MGT. The MGT consists of the penile urethra and the testes and 
comprises both simple and stratified epithelia (16). Although not 
necessary for normal penile functioning, the foreskin is thought 
to confer physical and immunological protection to the sensitive 
glans penis (Figure 1A) (17). The foreskin is a common site of 
entry for other STIs and is susceptible to micro-abrasions dur-
ing intercourse, which likely leads to inflammation and resident 
HIV target cell exposure making it an important immunological 
area of the MGT (18). In the same way that HIV has evolved to 
exploit lymphoid structures to efficiently propagate systemically 
in the body (19), HIV utilizes the structures in the foreskin and 
urethra, along with the underlying immune cells, as a portal into 
lymphoid structures and systemic circulation.
The foreskin consists of a double layer of stratified epithelium 
containing squamous keratinocytes that covers the glans/corona 
and meatus of a flaccid penis (18). It believed that the removal 
of the majority of the foreskin epithelium through circumcision 
results in a “dry” keratinized epithelium of the glans/corona that 
is though to be more resistant to microabrasions during sexual 
intercourse and limiting the chances for HIV to contact target 
cells residing in dermis and epidermis, compared the “wet” 
mucosal epithelium of the glans/corona covered by the foreskin 
in uncircumcised men (25). The keratin layer is believed to pro-
vide the first line of innate defence against infection of the penile 
tissue although published data differs with regards to the degree 
of foreskin keratinization, and the difference between keratin 
thickness of the inner and outer foreskin tissues (26). In an uncir-
cumcised penis, the foreskin retracts during erection, exposing 
the glans penis as well as the inner foreskin, which is thought 
to be more susceptible to viral acquisition compared to other 
penile tissues (27). This is based on observations from explant 
studies that have shown the inner foreskin to be exhibit higher 
inflammatory cytokine responses and HIV target cell activation 
compared to the outer foreskin, leading to the hypothesis that 
HIV target cells in the inner foreskin have increased interaction 
with external factors (27, 28). During sexual intercourse, the 
inner foreskin is exposed to vaginal and/or rectal secretions and 
FiGURe 1 | Factors affecting Hiv infection of the male genital tract. (A) The foreskin consists of a double layer of stratified epithelium that covers the glans/
corona and meatus of a flaccid penis. (B) Circumcision results in the removal of the majority of the foreskin epithelium leaving a “dry” keratinized surface that is 
assumed to be resistant to HIV infection. Non-STI genital microbial populations have been shown to modulate genital inflammation through the antigen recognition, 
which may result in migration or activation of HIV target cells into the foreskin. Circumcision results in a removal of the moist sub-preputial space and decrease in 
anaerobic bacterial species, which are likely pro-inflammatory. (C) The foreskin is a stratified epithelium consisting of six epidermal layers namely stratum corneum 
(SC), stratum granulosum (SG), stratum spinosum (SS), and stratum basale (SB). HIV virions crosses the keratinized (light brown) epithelial border through micro 
abrasions that occur during sexual intercourse or through the formation of viral synapses between HIV-infected cells and epithelial cells (20). Langerhans’ Cells (LCs) 
reside within the epidermis where they are the first to encounter the virus (21). Activated LCs migrate into the lower dermal tissues, transferring the virus to resident 
dermal immune cells such as T cells, macrophages, and epithelial dendritic cells (DCs). Dendritic cells act as professional antigen presenting cells, phagocytosing 
virions, and migrating to the draining lymph nodes where they present HIV antigens to immature T cells and B cells (22). Intact virus can be trafficked into the lymph 
nodes by DCs and transferred to CD4+ T cells (23) where the virus replicates and is disseminated throughout the body (24). Asymptomatic STIs do not present 
clinically but inflammation still occurs on a cellular level. The release of pro-inflammatory cytokines by keratinocytes and dermal immune cells in response to an STI 
would result in recruitment and activation immune cells to the site of infection. This inflammatory environment would result in an accumulation of HIV target cells and 
therefore increase the efficiency of viral transmission in the case of an HIV infection.
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is susceptible to micro-abrasions, possibly creating additional 
portals for HIV entry.
The foreskin was shown to contain a high density of the 
HIV target cells (29, 30), and a higher density of CD4+ T cells 
and langerin expressing Langerhans’ cells (LCs) were identified 
in the inner compared to the outer foreskin (30, 31). Prodger 
et al. described an “inflammatory immune microenvironment” 
within the foreskin where they observed an upregulation of HIV 
co-receptors on CD4+ T cells as well as increased production of 
inflammatory cytokines, TNF-α, and IFN-γ by CD8+ T cells (32). 
A similar observation was made by Lemos et al., suggesting that 
the protective effects of circumcision may be due to the removal 
of inflamed tissue that is not only more permeable to HIV but 
would possess a higher density of HIV target cells (33).
Stratified epithelium, typically found on surfaces exposed to 
the environment, consists of multiple layers of epithelial cells 
forming a physical barrier against external pathogens (34). High 
numbers of immune cells, such as LCs, which serve as special-
ized antigen presenting cells, are typically present in stratified 
epithelium (35). LCs have been identified in the upper layers of 
the epidermis and are proposed to be the first cells to come into 
contact with HIV upon infection (36). Other HIV target cells 
such as CD4+ T cells, dendritic cells (DCs), and macrophages 
expressing C-type lectins reside in the lower dermis. The gp120 
subunit of HIV Env binds the C-type lectin langerin expressed 
by circulating LCs where after the virus is either internalized and 
degraded or transferred to a CD4+ T cell, depending on viral load 
(21, 31). DCs express the C-type lectin DC-SIGN, which is also 
able to bind to gp120 and may promote transfer of HIV-1 from 
DCs to CD4+ T cells (23, 37). Macrophages are able to selectively 
capture HIV-1-infected CD4+ T-cells leading to the infection and 
efficient transfer of HIV-1 from cell-to-cell (38) These cells are 
found in surfaces typical of the meatus (distal end of penile ure-
thra), fossa navicularis (opening), and foreskin (39). Keratinized 
stratified squamous epithelium spans the exterior of the glans 
penis and foreskin and transitions into non-keratinized stratified 
squamous epithelium in the fossa navicularis (Figure 1A) (16).
UReTHRA: THe MUCOSAL  
SURFACe OF THe MGT
In contrast to the stratified squamous epithelium of the foreskin, 
a simple layer of non-keratinized pseudo stratified columnar epi-
thelial cells is found along the penile urethra and provides a lower 
level of protection against HIV infection (Figure 1A) (39). The 
urethral epithelium has a high density of intraepithelial immune 
cells including CD8 T cells, natural killer cells, as well as HIV-1 
targets CD4 T cells, DCs, and macrophages (16). As the urethra 
is the primary site of infection for many bacterial and viral STIs, 
this mucosal surface represents an important component of the 
penile protective immune tract, bit also implicating it as a portal 
of entry to HIV and other STI that use these cells for produc-
tive infection during or after sexual intercourse (40, 41). Present 
knowledge of HIV infection through the urethra is incomplete due 
to the limited availability of fresh urethral samples, although cells 
expressing HIV-1 co-receptors have been identified at the urethral 
opening (42). It is thus conceivable that the urethral opening may 
be an underestimated vulnerable site of HIV infection in circum-
cised men (25). An ex vivo study on penile tissue obtained follow-
ing gender reassignment surgery found tissue explants from the 
foreskin, glans, meatus, and urethra to be equally susceptible to R5 
HIV-1 infection (43, 44). Another study using penile tissues from 
cadavers found the inner foreskin to be more susceptible to HIV-1 
infection compared to the outer foreskin, glans, shaft and urethral 
opening (44). Through the use of urethral tissue explants and the 
development of a novel in vitro reconstructed urethral mucosa, 
Ganor et al. identified the urethra as an entry site for HIV-1 infec-
tion, where urethral macrophages, and not T cells or LCs, were the 
initial HIV-1 target cells at the urethral opening (45). It is known 
that approximately 40% of men are not protected after MMC, and 
evidence pointing to the urethra as an HIV-1 portal suggests that 
further focus should be made at understanding viral acquisition 
at this unique mucosal surface.
THe iMPACT OF MMC AND  
OTHeR STis ON Hiv RiSK
Data from MMC trials give strong evidence for the protective 
effect of circumcision against HIV acquisition (13–15), although 
the findings were not as conclusive concerning other STIs. The 
Uganda trial showed that MMC of adolescent boys and men 
resulted in a 45% overall reduction in genital ulcerative disease 
(GUD) (46), and both Ugandan and South African trials showed 
a significant reduction in Herpes Simplex Virus-2 (HSV-2) 
acquisition (46, 47). Contradictory results emerged from the 
Kenyan trial indicating no significant decrease in HSV-2 infec-
tions as a result of MMC (48), suggesting that the reduction in 
HIV due to circumcision was independent of HSV-2 and GUD 
(48). Weiss et al. found that circumcision significantly reduced 
the risk of chancroid and syphilis but was only weakly associated 
with a reduction of HSV-2 infection (49). It was suggested that 
the warm, moist area beneath the foreskin encourages pathogenic 
growth and that stricter hygiene of the prenuptial space (between 
the foreskin and glans penis) is associated with lower HIV 
prevalence. This would indicate that the dynamic environment 
occupying this space has an effect on HIV risk (50, 51). Thus the 
removal of such an environmental niche for these pathogens is 
more protective against diseases that commonly cause lesions on 
the foreskin tissue, such as cancroid, compared to lesions caused 
by syphilis and HSV-2, both of which present more widely across 
the male genitalia (52). Follow up from the Kenyan trial demon-
strated that circumcision did not decrease the risk of Neisseria 
gonorrhea (NG), Chlamydia trachomatis (CT), and Trichomonas 
vaginalis and is thus not protective against non-ulcerative genital 
diseases (NUDs) (53). While there has been epidemiological 
evidence of decreased prevalence of cervical neoplasia if females 
with circumcised partners (54–56), observational studies have 
found inconsistent results with regards to impact of circumcision 
on the transmission of HPV to female partners (57, 58). Results 
from the Ugandan circumcision trial found a lower incidence of 
high-risk HPV infection in women with circumcised partners, 
leading the authors to hypothesize that male circumcision 
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involves a reduction of penile HPV carriage (59). Data on the 
effect of circumcision on HPV prevalence in men are inconsistent 
(60), and various studies have reported an increased prevalence 
of HPV infection in uncircumcised men (61). Hernandez et al. 
found that circumcision did not increase the risk HPV acquisi-
tion, but rather reduced viral clearance for both oncogenic and 
non-oncogenic forms of the virus (62). The higher prevalence 
of HPV in uncircumcised men therefore could be attributed to 
a longer duration of infection rather than increased acquisition 
(62), highlighting that pathogen-specific factors need to be con-
sidered in the epidemiology of STIs in men.
Despite the seeming disparity on the effectiveness of MMC 
in reducing the risk for other STIs, there is evidence to indicate 
reductions in the incidence of GUDs following MMC although 
the biological mechanism through which this would impact HIV 
risk is unclear. It is biologically plausible and likely that mucosal 
disruptions as result of ulcerative STIs would provide additional 
routes of transmission for HIV acquisition in males. In addition, 
inflammation from STIs could increase the efficiency of HIV 
infection by recruiting and activating HIV target cells that reside 
and migrate to the foreskin tissues (33). This inflammatory effect 
may persist after clearance of the infection as demonstrated by 
Donoval et al. who found a higher proportion of HIV target cells 
in the foreskins of men with a history of STIs compared to those 
who had no STI history (63). Sbazo et al. have also suggested that 
the reduction of the highly vascularized frenulum, which is sus-
ceptible to trauma during sexual intercourse as well as ulcerative 
lesions, is one of the mechanisms by which circumcision prevents 
the synergy found between HIV and others STIs (64).
ARe ASYMPTOMATiC STis eLevATiNG 
Hiv ACQUiSiTiON RiSK iN MALeS?
Sexually transmitted infections have been identified as a signifi-
cant factor increasing the risk of transmission and acquisition of 
HIV (65, 66), where pre-existing STIs increase the risk of HIV 
acquisition by two to threefold (67) and that ulcerative STIs are an 
even higher risk factor than non-ulcerative STIs. These findings 
led to the hypothesis that STI treatment may be an effective HIV 
intervention strategy in populations where HIV and other STIs 
are prevalent. Initial results from a randomized controlled trial 
(RCT) in Mwanza, Tanzania showing a 38% reduction of HIV 
incidence as a result of treating STIs (68). However, subsequent 
data from nine RCTs could not reproduce this finding and there 
was no significant reduction of HIV incidence when symptomatic 
STIs were treated (65). These incongruous results have brought 
into question whether symptomatic STI treatment should be seen 
as an HIV intervention (69). Such a syndrome-based approach 
to STI management, employed by multiple countries in SSA, 
may underestimate the impact of subclinical inflammation due 
to asymptomatic and non-ulcerative STIs that may contribute to 
HIV susceptibility. Regardless of visible ulcerations, HSV-2 has 
been linked to an approximately threefold increased risk of HIV 
acquisition.
A case for persistent immune activation was observed after 
successful treatment of HSV-2 with Acyclovir, where increased 
expression of mucosal CCR5+ CD4+ T-cells remained at the sight 
of herpetic ulcers long after infection had been cleared (70). 
These findings would suggest that an initial immune activation 
event results in the persistence of HIV target cells in the MGT 
long after HSV-2 ulcerative resolution. Prodger et al. observed a 
higher proportion of HIV target CCR5+ T cells in the foreskins of 
Ugandan men with asymptomatic HSV-2 (71), supporting previ-
ous findings that HSV-2 infection increases the density of HIV 
target cells in the foreskin (72). Collectively, these data support 
the hypothesis that an asymptomatic or cleared HSV-2 infection 
may increase the susceptibility of the foreskin to HIV infection. 
In addition to an increased density of HIV target cells, asympto-
matic HSV-2 has been associated with decreased expression of 
the epithelial junction protein Claudin in the foreskin, creating a 
compromised epithelial barrier that may be more susceptible to 
HIV-1 infection (73). Experiments using genital epithelial mon-
olayers demonstrated that exposure to HIV-1 directly impairs 
mucosal barrier integrity through the disruption of tight junction 
markers, namely ZO-1 and Occulin enhancing HIV viral entry to 
sub mucosal targets (74). The disruption of the mucosal barrier, 
as a result of direct HIV exposure or coinfection with another 
STI, and the resultant epithelial cell induced inflammation (74) 
may be another mechanism HIV utilizes to gain access to target 
cells in the genital sub mucosa.
THe PeNiLe MiCROBiOMe  
AND iMMUNe iNTeGRiTY
The link between the microbiome and immunity has clearly been 
shown in the intestine (75, 76) and the way by which commensal 
microbiota, and released metabolites, shapes immunity in the 
skin is a focus of current research (77–79). Circumcision has been 
shown to alter the diversity and prevalence of the penile micro-
biota – a potential mechanism explaining the protective effect of 
circumcision against HIV (80, 81). Non-STI-genital microbial 
populations have been shown to modulate genital mucosal 
inflammation through antigen recognition and thus increase HIV 
risk through the activation of HIV target cells (82, 83). Price et al. 
showed that the microbiota of the coronal sulcus, the junction 
between the shaft and glans of the penis, predominately consists 
of anaerobic and putative vaginal taxa prior to circumcision and 
that anaerobes and skin taxa dominate following circumcision 
(81). Similarly distinct microbiota were shown to differentiate 
the coronal sulcus of circumcised and uncircumcised men (84). 
There was no difference between the microbial diversity within 
first pass urine samples, as a measure of urethral microbiome, 
collected from the same men, before and after circumcision, 
indicating that circumcision has no impact on the microbial 
diversity of the urethra (84). The moist sub-preputial space below 
the foreskin is thought to provide an anoxic microenvironment 
that harbors anaerobic bacterial species (81, 85). Predominantly 
anaerobic vaginal microbiota associated with bacterial vaginosis 
(BV) in women increases inflammation and HIV susceptibility 
(86, 87) in the female genital tract. Circumcision has been associ-
ated with a reduction of BV in female partners (88, 89) as well as 
a reduction of anaerobic bacterial species colonizing the coronal 
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suculus (81). The pro-inflammatory microbial community of the 
sub-preputial space may have a knock-on effect on other possible 
points of HIV entry as the foreskin covers the urethral opening 
in the majority of uncircumcised men (85). Based on this, it is 
postulated that the anaerobes on the uncircumcised penis are 
likewise pro-inflammatory, and thus result in migration or activa-
tion of HIV target cells into the foreskin (81), thereby increasing 
the likelihood of HIV infection through the urethra and foreskin 
in uncircumcised men (25) (Figure 1B).
DOeS Hiv-1 eXPLOiT THe MGT?
The role of subclinical inflammation in increasing susceptibility of 
the foreskin to HIV infection is unclear, especially in developing 
countries where a syndrome-based approach to STI management 
is followed. A high prevalence of commonly asymptomatic STIs 
such as CT and NG have been reported in high-risk MSM cohorts 
(90, 91), although there is little data on the prevalence of asympto-
matic STIs in the general population. Asymptomatic STIs in men 
may be the driver of elevated pro-inflammatory cytokines and 
chemokines in foreskin tissue and the urethra, thereby recruiting 
activated HIV target cells to the site of infection (Figure  1C). 
Endocervical epithelial cells are the predominant niche for ini-
tial infection of Chlamydia, a primarily asymptomatic STI (92) 
and is one of the most prevalent STI in both men and women. 
Chlamydia infection leads to an inflammatory cascade associated 
with an influx of HIV-1 target cells as a result of the release of 
pro-inflammatory cytokines by epithelial cells (93). Buckner et al. 
showed that HIV infection of CD4+ CCR5+ cell lines is enhanced 
by exposure to supernatant from Chlamydia-infected epithelial 
cells. This infers that Chlamydia infection may facilitate viral 
infection in the local environment (94).
We thus posit that asymptomatic STIs increase the risk of 
HIV infection through subclinical inflammation that is modu-
lated by epithelial dysbiosis. The inflammatory events in the 
MGT upon STI infection are a natural sequelae for protective 
immunity around the penile tissue. However, such subclinical 
inflammation in the foreskin/urethra of uncircumcised males 
and the urethra in circumcised men represent a perfect niche 
for HIV-1 to exploit in establishing a successful productive infec-
tion. Similar to the female genital tract and all human mucosal 
surfaces, innate immune defences such as mucus production, 
pattern recognition receptors, and antimicrobial peptide pro-
duction are present in the MGT [Reviewed in Ref. (16)]. There is 
evidence that penile immunity is quite active in the FS, urethra, 
and within the epithelial tissues (95) and it would seem intuitive 
that immune protection within the MGT is a critical survival 
advantage to the host and therefore used to a survival advantage 
by HIV-1.
CONCLUSiON
Medical male circumcision has been widely accepted as an effec-
tive intervention strategy for the heterosexual transmission of 
HIV (96, 97) and has been shown to be a more effective interven-
tion strategy than STI treatments, vaccines, and microbicides 
(29). Complications as a result of MMC were low after the MMC 
trials (between 1.7 and 7.6%) and were mostly of minor clinical 
significance (98, 99). The prevalence of traditional circumcision 
performed in a non-clinical setting is thought to be between 
20 and 80% in Eastern and Southern Africa (54) and has been 
associated with serious medical complications (100). Although 
the World Health Organisation reported 9.1 million MMCs per-
formed between 2007 and 2014 in priority countries in East and 
Southern Africa (97), traditional circumcision in is still prevalent 
in these regions for reasons that are both cultural and based on 
health service capacity (100). More research is needed to evaluate 
the impact of traditional circumcision on HIV transmission rates 
and well as on the acceptability of MMC in communities were 
traditional circumcision is practiced.
Little is known about mechanisms by which HIV gains access 
to the MGT. While circumcision has been shown to be an effective 
HIV intervention strategy, 40% of circumcised men are not pro-
tected after MMC, and condom usage is still regarded the best HIV 
prevention method, despite low adherence globally (101–103). 
The efficiency of MMC indicates that the removal of the foreskin 
reduces a natural environmental niche for HIV-1 acquisition in 
the MGT. Due to limited access to penile tissue, there are large 
gaps of knowledge regarding routes of HIV acquisition in males 
other than the foreskin. More studies on how HIV-1 has evolved to 
exploit the MGT architecture – utilizing subclinical inflammation 
and microbial dysbiosis to its advantage – are required to inform 
targeted intervention strategies that can prevent acquisition. In 
addition, a multidisciplinary approach marrying the biology of 
transmission and acquisition with the identity of sexual networks 
between MSM and heterosexual populations is a way to under-
stand the HIV-1 epidemic and ways to mitigate transmission.
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